Celularity Inc. (CELU) vs DarioHealth Corp. (DRIO)
A side-by-side comparison of Celularity Inc. and DarioHealth Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CELU
Celularity Inc.
$1.72HealthcareDelayed quote: Oct 6, 2026, 11:32 AM EDT
DRIO
DarioHealth Corp.
$6.29HealthcareDelayed quote: Oct 6, 2026, 11:34 AM EDT
Total return — CELU vs DRIO
growth of $100 · dividends reinvested · last 7yCELU -98.3% (-43.9%/yr)DRIO -97.7% (-41.5%/yr)DRIO compounded faster over this window
CELU DRIO
CELU vs DRIO: by the numbers
- •CELU is the larger company ($50M vs $46M market cap).
- •DRIO is profitable (322.77% net margin) while CELU runs a net loss (-375.77%).
- •DRIO grew revenue faster over the past five years (10.10% vs 8.31% CAGR).
Metrics side by side
Valuation
| Metric | CELU | DRIO |
|---|---|---|
| P/E ratio | N/A | 9.12 |
| P/S ratio | 2.62 | 2.19 |
| P/B ratio | N/A | 0.83 |
Profitability
| Metric | CELU | DRIO |
|---|---|---|
| Gross margin | 79.62% | 56.09% |
| Operating margin | -230.92% | -163.94% |
| Net margin | -375.77% | 322.77% |
| ROE | N/A | 123.04% |
| ROIC | -192.99% | -78.42% |
Growth (annualized)
| Metric | CELU | DRIO |
|---|---|---|
| Revenue CAGR (5Y) | 8.31% | 10.10% |
| Total return CAGR (5Y) | -52.57% | -52.92% |
Frequently asked
- Which has grown faster, CELU or DRIO?
- Over the past five years, DRIO grew revenue faster — CELU at a 8.31% CAGR versus DRIO at 10.10%.
- Is CELU or DRIO more profitable?
- DRIO runs the higher net margin — CELU at -375.77% versus DRIO at 322.77%.
- How have CELU and DRIO total returns compared?
- Over the past 5 years, CELU delivered -52.57% and DRIO delivered -52.92% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
DarioHealth P/E ratioCelularity ROEDarioHealth ROECelularity operating marginDarioHealth operating marginCelularity revenue growthDarioHealth revenue growthCelularity free cash flowDarioHealth free cash flow
Celularity & DarioHealth appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.